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Abstract
Background: Oral sex among teenagers is on the rise. Similarity between the oral flora and organisms recovered from 
nongonococcal urethritis and prostatitis, points to retrograde entry of bacteria from oral cavity into the urethra 
following insertive oral intercourse.
Presentation of the hypothesis: Chlorhexidine has a wide spectrum of anti-bactericidal activity encompassing gram 
positive and negative bacteria. It is also effective against HIV and HBV. It produced large and prolonged reductions in 
salivary bacterial counts within 7-h of its use. Hence, it would seem logic to postulate that rinsing with chlorhexidine 
before oral sex will be effective for prevention of retrograde entry of bacteria from oral cavity into the urethra. The 
recommendation for rinsing will be: 15 ml of a 0.12% or 10 ml of 0.2% chlorhexidine rinse for 30 seconds. Also other 
drug delivery systems such as chlorhexidine chewing gum or spray can be used.
Testing the hypothesis: Men suffering from recurrent nongonococcal urethritis or prostatitis are good subjects for 
testing the hypothesis. They perform genital safe sex via consistent use of condom. Yet they generally received 
unprotected insertive oral intercourse. Chlorhexidine can be used for prevention of recurrences of the disease.
Implications of the hypothesis: The chlorhexidine will be a new, easy, attractive and effective method for reduction 
of nongonococcal urethritis, prostatitis and epidydimitis following insertive oral intercourse. It is poorly absorbed from 
skin, mucosa and gastrointestinal tract indicating systemic safety of chlorhexidine. The agent does not cause any 
bacterial resistance and supra-infection.
Background
The first comprehensive study to examine the prevalence
of the oral sex was published in the Time magazine [1].
The report by the National Center for Health Statistics
was based on a computer-administered survey of over
12,000 Americans between the ages of 15 and 44, and
stated that over half of the teenagers questioned have had
o r a l  s e x .  T h i s  r e p o r t  p r o v i d e d  e v i d e n c e  t h a t  o r a l  s e x
among teenagers is "on the rise".
However, direct and indirect evidence from studies of
patients with nongonococcal urethritis and prostatitis
points to retrograde entry of bacteria from the oral cavity
to the urethra following oral intercourse as primary mode
of transmission for pathogenesis of infection [2-6]. Evi-
dence is based upon similarity of organisms recovered
from infection and normal oropharyngeal flora such as
Streptococci, Haemophilus species, N. meningitides,
Adenoviruses and HSV-1 [4].
Nevertheless, if sexually transmitted disease (STD) sta-
tus is unknown for partners, condoms or dental dams is
recommended when performing or receiving oral inter-
course. The plastic wrap may also be used as a barrier
during oral intercourse, but many find that the thickness
of the plastic dulls sensation [7].
The aim of this hypothesis is to suggest a new, easy,
attractive and effective method for prevention of non-
gonococcal urethritis, prostatitis and epidydimitis follow-
ing oral intercourse.
Presentation of the hypothesis
Chlorhexidine is a bisbiguanide antiseptic which has a
wide spectrum of bactericidal activity encompassing
gram positive and gram negative bacteria. It is also effec-
tive against some fungi and yeast, including Candida, and
some lipophilic viruses including HIV and HBV [8].
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Chlorhexidine (C22 H30 Cl 2N10) is a strong base and dica-
tionic at pH levels above 3.5. The bactericidal effect of
chlorhexidine is due to the cationic nature of the agent
binding to extra microbial complexes and negatively
charged microbial cell wall, thereby altering the cells
osmotic equilibrium [9].
Of more interest, the usage of 0.12% or 0.2% commer-
cial formulations of chlorhexidine mouthwashes pro-
duces a large and prolonged reductions in salivary
bacterial counts within the 7-h period [10]. Hence, it
would seem logic to postulate that prophylactic rinsing
with chlorhexidine before oral intercourse will reduce
retrograde entry of bacteria via the urethra. The recom-
mendation for rinsing is 15 ml of a 0.12% or 10 ml of 0.2%
oral chlorhexidine rinse for 30 seconds [8]. The previous
published date recommended 2 hour post brushing to
optimize anti-microbial activities of chlorhexidine rinse
[8]. Also other drug delivery systems such as chlorhexi-
dine chewing gum [11] or spray [12] can be used.
In the same way, chlorhexidine have been used success-
fully for controlling the oropharyngeal flora and accord-
ingly prevention of the ventilator-associated pneumonia
involving aspiration of bacteria from the oropharynx into
the lung [13,14].
Testing the hypothesis
Men suffering from recurrent nongonococcal urethritis
or prostatitis are good subjects for testing the hypothesis.
They perform genital safe sex via consistent use of con-
dom. Yet they generally received unprotected oral inter-
course. Chlorhexidine can be used for prevention of
recurrences of the disease.
Implications of the hypothesis
The chlorhexidine rinse will be a new, easy, attractive and
effective method for reduction of nongonococcal urethri-
tis, prostatitis and epidydimitis following insertive oral
intercourse. It is poorly absorbed from skin, mucosa and
gastrointestinal tract indicating systemic safety of chlor-
hexidine. The agent does not cause any bacterial resis-
tance and supra-infection.
Current literatures [2-6,8] support prophylactic use of
chlorhexidine rinse as a safe and effective way for reduc-
tion of retrograde entry of bacteria from oral cavity to the
urethra following insertive oral intercourse via large and
prolonged reductions of the oral bacterial counts. This
approach will be a new, easy, attractive and effective
method for prevention of nongonococcal urethritis, pros-
tatitis and epidydimitis following insertive oral inter-
course.
Oral health professionals have used chlorhexidine for
over three decades. It is poorly absorbed from skin,
mucosa and gastrointestinal tract [8,15] indicating sys-
temic safety of chlorhexidine. The agent does not cause
any bacterial resistance and supra-infection following
long term oral usage [8].
Despite the excellent anti-microbial property of chlor-
hexidine, clinical usage of the agent is limited by the pos-
sible local side effects including: 1) reversible staining of
the teeth and tongue 2) transient taste perturbation 3)
oral mucosal erosion 4) occasional parotid gland swelling
and 5) increases supra gingival calculus formation [8].
The most common and problematic side effect is revers-
ible staining. Staining is mild and visible within a week
and becomes moderate in 50% of patient after six months
following continues usage of chlorhexidine rinse each 12
h. The long term use of chlorhexidine rinse is associated
with heavy reversible staining. The staining is more pro-
nounced in patients who have heavier accumulations of
plaque [8]. The long term use of chlorhexidine rinse for
the purpose of reduction of STD has not been evaluated
yet.
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